Fujian Aonong Biological Technology Group, Inc. Ltd. (603363) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Fujian Aonong Biological Technology Group, Inc. Ltd.

Why is Fujian Aonong Biological Technology Group, Inc. Ltd. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of -1.62% and Operating profit at -185.37% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Flat results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY -562.34 MM
PRE-TAX PROFIT(Q) At CNY 53.3 MM has Fallen at -81.28%
NET PROFIT(Q) At CNY 53.17 MM has Fallen at -85.88%

With ROE of 35.16%, it has a very attractive valuation with a 4.09 Price to Book Value

Over the past year, while the stock has generated a return of 32.29%, its profits have risen by 132.5% ; the PEG ratio of the company is 0.1

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Fujian Aonong Biological Technology Group, Inc. Ltd. should be less than 10%
Overall Portfolio exposure to Other Agricultural Products should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Fujian Aonong Biological Technology Group, Inc. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Fujian Aonong Biological Technology Group, Inc. Ltd.

12.25%

0.16

42.29%

China Shanghai Composite

16.67%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.62%

EBIT Growth (5y)

-185.37%

EBIT to Interest (avg)

-1.50

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.58

Sales to Capital Employed (avg)

2.17

Tax Ratio

4.36%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.06%

ROE (avg)

11.72%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.09

EV to EBIT

-27.81

EV to EBITDA

93.64

EV to Capital Employed

3.04

EV to Sales

1.82

PEG Ratio

0.09

Dividend Yield

ROCE (Latest)

-10.93%

ROE (Latest)

35.16%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

NET PROFIT(HY)

At CNY 195.62 MM has Grown at 137.12%

ROCE(HY)

Highest at 238.02%

RAW MATERIAL COST(Y)

Fallen by -142.79% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 9.17 times

NET SALES(Q)

Highest at CNY 2,378.23 MM

-13What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY -562.34 MM

PRE-TAX PROFIT(Q)

At CNY 53.3 MM has Fallen at -81.28%

NET PROFIT(Q)

At CNY 53.17 MM has Fallen at -85.88%

DEBTORS TURNOVER RATIO(HY)

Lowest at 6.62 times

Here's what is working for Fujian Aonong Biological Technology Group, Inc. Ltd.

Net Sales

Highest at CNY 2,378.23 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 2,378.23 MM has Grown at 17.97%

over average net sales of the previous four periods of CNY 2,015.98 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Inventory Turnover Ratio

Highest at 9.17 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -142.79% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Fujian Aonong Biological Technology Group, Inc. Ltd.

Pre-Tax Profit

At CNY 53.3 MM has Fallen at -81.28%

over average net sales of the previous four periods of CNY 284.66 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 53.17 MM has Fallen at -85.88%

over average net sales of the previous four periods of CNY 376.67 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY -562.34 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debtors Turnover Ratio

Lowest at 6.62 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio